Dr. Brian O’Connor Joins Veritas Pharma Advisory Board
January 02, 2018 03:05 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that Dr. Brian O’Connor,...
Veritas and Cannevert Complete Prestudy Visit of the Puerto Rico Clinical Trial Facility
December 29, 2017 03:05 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces that it has completed a prestudy...
Veritas Pharma Subsidiary Receives Health Canada Dealer Licence
December 28, 2017 03:05 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces that Health Canada has issued its...
Veritas Hires Medical Director to Advise Physicians & Regulators on the Application of Cannevert’s Experimental Results with Cannabis to Clinical Practice & Public Policy
December 08, 2017 03:05 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce the hiring of Dr. M....
Veritas’ Research Arm Cannevert Signs a Material Transfer Agreement with the Institute for Medical Cannabis of Puerto Rico
December 05, 2017 03:05 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Dec. 05, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces its research arm, Cannevert...
Veritas Pharma Appoints of BC's "Top 40 Under 40" Robert Dawson – a Highly Regarded Marketing & Innovation Expert to Its Advisory Board
November 29, 2017 16:30 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces the appointment of Mr. Robert “Rob”...
US Patent Office Acknowledges Provisional Patent Application for Use of Specific Cannabis Strain to Enhance Opioid Analgesia Filed by Veritas’ Research Arm Cannevert
November 28, 2017 03:05 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces its research arm, Cannevert...
Veritas’ Research Arm Cannevert Therapeutics Signs Letter of Intent with Fundación de Investigación (FDI) of Puerto Rico USA to Begin Human Trials of Its Lead Cannabis Strain for Pain
November 20, 2017 03:05 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 20, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces that its research arm, Cannevert...
A Provisional Patent Application for Use of Specific Cannabis Strain in Neuropathic Pain Filed With the US Patent Office
November 07, 2017 04:00 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces that its research arm, Cannevert...